insights_auto
Why is TWST down 15.54%?
Dive Deeperchevron_right
TWST:NASDAQ
Twist Bioscience Corp
$129.04
arrow_downward
-15.54%(-23.74) 1D
$128.49
arrow_downward
-0.43% (-0.55)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$153.17
High
$154.22
Low
$128.29
Mkt. cap
8.55B
Avg. vol.
2.94M
Volume
2.67M
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
Open
$153.17
High
$154.22
Low
$128.29
Mkt. cap
8.55B
Avg. vol.
2.94M
Volume
2.67M
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
MarketWatch
·
1 hour ago
Nasdaq-100 tumbles into its third correction this year as AI worries mount
Stocktwits
·
37 minutes ago
S&P 500, Nasdaq Drop As Capex Concerns Grip Tech Investors, Outweighing US-Iran Diplomacy Hope — ORCL, META, PLTR, AAPL In Focus
GuruFocus
·
47 minutes ago
Lotus Technology (LOT) Receives Nasdaq Notice for Minimum Bid Pr
Bloomberg.com
·
1 hour ago
Nasdaq Slide Clouds Asian Open, Oil Holds Losses: Markets Wrap
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp